Patents by Inventor Kevin Anthony Hart

Kevin Anthony Hart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090142351
    Abstract: A novel gene PGC-3, and its role in regulating the transcriptional activity of PPAR? in adipose tissue. PGC-3 is highly expressed in human white adipose tissue and has utility in the development of new therapeutic agents for use in the treatment of obesity and other related disorders such as non-insulin dependent diabetes mellitus, insulin resistance syndrome, dyslipidemia, and atherosclerosis.
    Type: Application
    Filed: October 29, 2007
    Publication date: June 4, 2009
    Applicant: AstraZeneca AB
    Inventors: Kevin Anthony Hart, Carl Thomas Montague, Antonio Vidal-Puig
  • Patent number: 7306922
    Abstract: A novel gene PGC-3, and its role in regulating the transcriptional activity of PPAR? in adipose tissue. PGC-3 is highly expressed in human white adipose tissue and has utility in the development of new therapeutic agents for use in the treatment of obesity and other related disorders such as non-insulin dependent diabetes mellitus, insulin resistance syndrome, dyslipidemia, and atherosclerosis.
    Type: Grant
    Filed: September 12, 2001
    Date of Patent: December 11, 2007
    Assignee: AstraZeneca AB
    Inventors: Kevin Anthony Hart, Carl Thomas Montague, Antonio Vidal-Puig
  • Publication number: 20040093626
    Abstract: The use of the G protein coupled receptor GPR3 to identify appetite control agents and diagnostic agents.
    Type: Application
    Filed: June 13, 2003
    Publication date: May 13, 2004
    Inventors: John Charles Brennand, Kevin Anthony Hart
  • Publication number: 20040093627
    Abstract: The use of the G protein coupled receptor GPR56 to identify appetite control agents and diagnostic agents.
    Type: Application
    Filed: June 13, 2003
    Publication date: May 13, 2004
    Applicant: AstraZeneca AB
    Inventors: John Charles Brennand, Kevin Anthony Hart
  • Publication number: 20040077536
    Abstract: A gene PGC-3 PPAR gamma coactivator-3, and it's role in regulating the transcriptional activity of peroxisome proliferator activated receptor-Y PPAR-Y in adipose tissue. PGC-3 is highly expressed in human white adipose tissue and has utility in the development of new therapeutic agents for use in the treatement of obesity and other related disorders such as non-insulin dependent diabetes mellitus, insulin resistance syndrome, dyslipidemia, and atherosclerosis.
    Type: Application
    Filed: March 13, 2003
    Publication date: April 22, 2004
    Inventors: Kevin Anthony Hart, Carl Thomas Montague, Antonio Vidal-Puig
  • Publication number: 20040053812
    Abstract: The use of the G protein coupled receptor GPR22 to identify appetite control agents and diagnostic agents.
    Type: Application
    Filed: June 13, 2003
    Publication date: March 18, 2004
    Applicant: AstraZeneca AB
    Inventors: John Charles Brennand, Kevin Anthony Hart
  • Publication number: 20020082412
    Abstract: The use of the G protein coupled receptor GPR3 to identify appetite control agents and diagnostic agents.
    Type: Application
    Filed: May 2, 2001
    Publication date: June 27, 2002
    Applicant: AstraZeneca AB
    Inventors: John Charles Brennand, Kevin Anthony Hart
  • Publication number: 20020040132
    Abstract: The use of the G protein coupled receptor GPR56 to identify appetite control agents and diagnostic agents.
    Type: Application
    Filed: May 2, 2001
    Publication date: April 4, 2002
    Applicant: AstraZeneca AB
    Inventors: John Charles Brennand, Kevin Anthony Hart